Evidence Hub

Impact of medication side effects on medication adherence and implications for treatment outcomes in patients with borderline personality disorder: a pilot study

Sarah Wazlawik, C. Oppenauer

BMC Psychiatry, 2026

48 participants

Abstract

Borderline Personality Disorder (BPD) is a severe mental illness characterized by unstable interpersonal relationships, affective instability, and impulsivity. While psychotherapy is the recommended first-line treatment, over 80% of BPD patients use psychotropic medication and often report side effects. This pilot study examines whether perceived medication side effects influence treatment outcomes in BPD, anxiety, and depression symptoms indirectly through their effect on medication adherence, with adherence conceptualized as a potential mediator of this relationship. This retrospective study included patients from the personality disorder unit at University Hospital Eggenburg. BPD diagnoses were confirmed using the Borderline Symptom List (BSL-23). Perceived side effects and medication adherence were assessed via self-report questionnaires at admission. Three mediation analyses examined the association between side effects and treatment outcomes (using the BSL-23, PHQ-9, and GAD-7 for BPD, depression, and anxiety symptoms, respectively), with adherence as a mediator and gender and baseline symptom severity as covariates. 84% of patients (n = 48) reported side effects, most commonly depression, fatigue, dizziness, and tremor. The leading cause of nonadherence was forgetting to take medication. The mediation analyses showed no indirect effect of X on Y via M (n = 31; BPD: indirect effect = 0.0011, 95% CI = [-0.0209, 0.0169], anxiety: indirect effect = 0.0038, 95% CI =…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free